MarketPeel
Insider Trading Intelligence
Pricing
…
JL

Jennifer Larson

BCAX
CHIEF FINANCIAL OFFICER · BICARA THERAPEUTICS INC. · CIK 0002149587
FILING MIX · LIFETIME100%/0%
BUYS
1
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Aug 2026
HOLDINGS NOW
285,000
AVG SELL PX
—
TRADE KIND
SHOWING 1 / 1
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Jennifer Larson. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
Not enough transaction history to chart holdings.
Trading cadence · quarterly flow
BUY ● SELL ●
2026
FLOW · 1 buys / 0 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
BCAX
BICARA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
285,000——285,000Aug 12, 2026Aug 14, 2026 ↗View →
Other insiders · BCAX
Loading peer insiders…
About this filer
CIK 0002149587
ROLE
Chief Financial Officer
PRIMARY
BCAX
COMPANIES
1
ACTIVE SINCE
Aug 2026
MARKETPEEL · /INSIDER/0002149587DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback